Browse Title Index


 
Issue Title
 
Vol 6, No 2 (2014): Mol Cell Pharmacol FDA Approves Keytruda for Advanced Melanoma Abstract   PDF
FDA News Release
 
Vol 1, No 5 (2009): Mol Cell Pharmacol FDA Approves Lysteda to Treat Heavy Menstrual Bleeding Abstract   PDF
FDA News Release
 
Vol 1, No 3 (2009): Mol Cell Pharmacol FDA Approves Multaq to Treat Heart Rhythm Disorder Abstract   PDF
FDA News Release
 
Vol 1, No 4 (2009): Mol Cell Pharmacol FDA Approves New Cholesterol-Lowering Drug Abstract   PDF
FDA News Release
 
Vol 2, No 3 (2010): Mol Cell Pharmacol FDA Approves New Combination Product Oral Contraceptive Abstract   PDF
FDA News Release
 
Vol 9, No 1 (2017): Mol Cell Pharmacol FDA Approves New Combination Treatment for Acute Myeloid Leukemia Abstract   PDF
FDA News Release
 
Vol 2, No 4 (2010): Mol Cell Pharmacol FDA Approves New Drug for Gout Abstract   PDF
FDA News Release
 
Vol 2, No 1 (2010): Mol Cell Pharmacol FDA Approves New Drug for Rheumatoid Arthritis Abstract   PDF
FDA News Release
 
Vol 5, No 2 (2013): Mol Cell Pharmacol FDA Approves New Drug to Treat HIV Infection Abstract   PDF
FDA News Release
 
Vol 5, No 2 (2013): Mol Cell Pharmacol FDA Approves New Drug to Treat Major Depressive Disorder Abstract   PDF
FDA News Release
 
Vol 1, No 4 (2009): Mol Cell Pharmacol FDA Approves New Drug to Treat Psoriasis Abstract   PDF
FDA News Release
 
Vol 1, No 3 (2009): Mol Cell Pharmacol FDA Approves New Drug Treatment for Type 2 Diabetes Abstract   PDF
FDA News Release
 
Vol 2, No 3 (2010): Mol Cell Pharmacol FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women Abstract   PDF
FDA News Release
 
Vol 7, No 3 (2015): Mol Cell Pharmacol FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer Abstract   PDF
FDA News Release
 
Vol 7, No 3 (2015): Mol Cell Pharmacol FDA Approves New Orphan Drug to Treat Pulmonary Arterial Hypertension Abstract   PDF
FDA News Release
 
Vol 8, No 1 (2016): Mol Cell Pharmacol FDA Approves New Psoriasis Drug Taltz Abstract   PDF
FDA News Release
 
Vol 4, No 2 (2012): Mol Cell Pharmacol FDA Approves New Treatment for Advanced Colorectal Cancer Abstract   PDF
FDA News Release
 
Vol 7, No 1 (2015): Mol Cell Pharmacol FDA Approves New Treatment for Advanced Pancreatic Cancer Abstract   PDF
FDA News Release
 
Vol 1, No 5 (2009): Mol Cell Pharmacol FDA Approves New Treatment for Chronic Lymphocytic Leukemia Abstract   PDF
FDA News Release
 
Vol 5, No 3 (2013): Mol Cell Pharmacol FDA Approves New Treatment for Hepatitis C Virus Abstract   PDF
FDA News Release
 
Vol 7, No 2 (2015): Mol Cell Pharmacol FDA Approves New Treatment for HIV Abstract   PDF
FDA News Release
 
Vol 2, No 3 (2010): Mol Cell Pharmacol FDA Approves New Treatment for Late-Onset Pompe Disease Abstract   PDF
FDA News Release
 
Vol 4, No 1 (2012): Mol Cell Pharmacol FDA Approves New Treatment for Most Common Type of Skin Cancer Abstract   PDF
FDA News Release
 
Vol 2, No 4 (2010): Mol Cell Pharmacol FDA Approves New Treatment for Prostate Cancer Abstract   PDF
FDA News Release
 
Vol 2, No 1 (2010): Mol Cell Pharmacol FDA Approves New Treatment for Type 2 Diabetes Abstract   PDF
FDA News Release
 
Vol 2, No 5 (2010): Mol Cell Pharmacol FDA Approves New Treatment Option for Late-Stage Breast Cancer Abstract   PDF
FDA News Release
 
Vol 9, No 2 (2017): Mol Cell Pharmacol FDA Approves New Treatment to Reduce the Risk of Breast Cancer Returning Abstract   PDF
FDA News Release
 
Vol 2, No 2 (2010): Mol Cell Pharmacol FDA Approves New Use of Xifaxan for Patients with Liver Disease Abstract   PDF
FDA News Release
 
Vol 8, No 2 (2016): Mol Cell Pharmacol FDA approves new, targeted treatment for bladder cancer Abstract   PDF
FDA News Release
 
Vol 5, No 3 (2013): Mol Cell Pharmacol FDA Approves Nexavar to Treat Type of Thyroid Cancer Abstract   PDF
FDA News Release
 
Vol 6, No 3 (2014): Mol Cell Pharmacol FDA Approves Opdivo for Advanced Melanoma Abstract   PDF
FDA News Release
 
Vol 7, No 2 (2015): Mol Cell Pharmacol FDA Approves Opdivo to Treat Advanced form of Kidney Cancer Abstract   PDF
FDA News Release
 
Vol 5, No 3 (2013): Mol Cell Pharmacol FDA Approves Opsumit to Treat Pulmonary Arterial Hypertension Abstract   PDF
FDA News Release
 
Vol 5, No 2 (2013): Mol Cell Pharmacol FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment Abstract   PDF
FDA News Release
 
Vol 7, No 2 (2015): Mol Cell Pharmacol FDA Approves Portrazza to Treat Advanced Squamous Non-small Cell Lung Cancer Abstract   PDF
FDA News Release
 
71 - 105 of 215 Items << < 2 3 4 > >> 



LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.